Bovine-based Collagen for Biomedical Applications Market Size was valued at USD 1.2 Billion in 2022. The Bovine-based Collagen for Biomedical Applications market industry is anticipated to grow from USD 1.33 Billion in 2023 to USD 2.97 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 10.60% during the forecast period (2024 - 2032). Demand for dental and orthopedic procedures is increasing, and there is a high demand for collagen derived from cows to treat a variety of diseases is a key market drivers boosting the expansion of the market.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Market CAGR for Bovine-based Collagen for Biomedical Applications is being driven by the increasing need for cutting-edge products to cure wounds. The connective tissues and skin of mammals are the only places in which animals contain the protein collagen. Cattle is the primary source of collagen, accounting for a significant portion of the business, however collagen can also be obtained from chicken, pig, fish, and other animals.
Additionally, the market is expanding because there is an increasing need for collagen derived from cows in biomedical applications to treat a range of medical disorders. This industry is growing because of the rising need for orthopedic and dental operations. In the upcoming years, the market is probably going to grow as a result of increased R&D efforts for the creation of regenerative and wound healing medications. Additionally, factors like the widespread use of the products in wound dressings, collagen-based scaffolds, skin substitutes, hemostats, bone graft replacements, cartilage repairs, and an increase in the geriatric population, as well as an increase in burn and trauma cases, are driving the market's growth.
The market is expanding as a result of the usage of collagen derived from cows in biomedical applications to treat a range of illnesses, including osteoporosis, arthritis, and improving skin health. Bovine is used in various stages of development. For example, the fetal bovine dermis is used for tendon encouragement, skin and wound recovery (in the form of collagen matrix); the neonatal bovine dermis is used for plastic and reconstructive surgery, hernia repair, and muscle flap reinforcement; and the adult bovine pericardium is used for the same purposes. There have also been reports of corneal collagen shields for ocular administration. Hydrophilic plastics, which are used to make bandage soft contact lenses, are commonly used to protect eyes with a variety of issues, such as recurrent epithelial erosions following ocular herpes infection and non-healing epithelial abnormalities following corneal transplantation or refractive surgery.
For instance, according to a March 2022 International Journal of Environmental Research and Public Health study, osteoporosis and osteopenia were found to be prevalent in postmenopausal women in Punjab (India) at rates of 30,50% and 44,20%, respectively. Thus, result in driving the Bovine-based Collagen for Biomedical Applications market revenue.
Bovine-based Collagen for Biomedical Applications Application Insights
The Bovine-based Collagen for Biomedical Applications Market segmentation, based on Application includes Bone Graft Substitutes, Collagen-based Scaffolds, Hemostats, Skin Substitutes, Cartilage Repairs, and Others. In 2023, the Bone Graft Substitutes segment dominated the market. A bone substitute is a manufactured, inorganic, or organically organic mixture that can be used to treat a bone deficit in place of autogenous or allogenous bone. Collagen and carbonate-substituted hydroxyapatite comprise the majority of bone. Such components are likely to produce an implant with superior behavior. The growing incidence of bone-related illnesses like osteoporosis and arthritis is driving the segment's rise.
Figure 1: Bovine-based Collagen for Biomedical Applications Market, by Application, 2023 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North American Bovine-based Collagen for Biomedical Applications market area will rule this market, due to elements such the increased prevalence of bone-related illnesses, the aging population, improved healthcare facilities, public knowledge of new technologies among stakeholders in the healthcare sector, and the concentration of market competitors in the area.
Further, the major countries studied in the market report are China, Japan, India, Australia, South Korea, Brazil, Germany, France, the UK, Italy, and Spain.
Figure 2: Bovine-based Collagen for Biomedical Applications Market Share By Region 2023 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe Bovine-based Collagen for Biomedical Applications market has the second-largest portion of the market. Some of the factors expected to propel the market expansion include more research partnerships and beneficial government initiatives. Further, the German Bovine-based Collagen for Biomedical Applications market hold the largest market share, and the UK Bovine-based Collagen for Biomedical Applications market was the European market with the quickest rate of growth.
The Asia-Pacific Bovine-based Collagen for Biomedical Applications Market is anticipated to expand between 2024 and 2032 at the quickest CAGR. This is because of the growing number of elderly people and increased health care costs. Moreover, China’s Bovine-based Collagen for Biomedical Applications market hold the biggest market share, and the Indian Bovine-based Collagen for Biomedical Applications market was the Asia-Pacific region's fastest-growing market.
Leading market players are putting a lot of money on R&D to expand their product lines, which will help the market for weight reduction products grow. Additionally, market players are engaging in a range of calculated initiatives to increase their worldwide presence, with important market developments involving the introduction of new products, contracts, M&A transactions, increased investment, and cooperation with other enterprises. To grow and endure in an increasingly cutthroat and dynamic market, Bovine-based Collagen for Biomedical Applications industry must provide reasonably priced goods.
Manufacturing locally is one of the primary business techniques used by manufacturers to cut operational costs in the global Bovine-based Collagen for Biomedical Applications industry to help customers and expand the market segment. In recent years, the Bovine-based Collagen for Biomedical Applications industry has provided some of the biggest benefits to medicine. Major players in the Bovine-based Collagen for Biomedical Applications market, including Rousselot, BBI Solution, Foodmate Co. Ltd, Botiss Biomaterials GmbH, Medtronic PLC, Kyeron, Collagen Matrix Inc., and others, are engaging in research and development activities in an effort to boost market demand.
Medtronic plc is a US-based medical device manufacturer. The company now has its operational, executive, and legal headquarters in Minneapolis, Minnesota, and its operating headquarters in Ireland as a result of its 2015 acquisition of the Irish company Covidien. It employs approximately 90,000 people and conducts business in more than 150 countries, with the United States being its primary market. It creates and produces medical devices and treatments. In January 2020, the business declared its plan to purchase Stimgenics, LLC and their differential target multiplexed spinal cord stimulation therapy as their main treatments.
Foodmate Co., Ltd. is a leading manufacturer of collagen and gelatin, with an R&D team with more than a decade of experience. Foodmate Co., Ltd. is a fully owned subsidiary manufacturing plant of Foodchem Group, which is among the top three suppliers and manufacturers of food ingredients in China. The company has achieved notable success in the sector. Natural, wholesome, and useful food ingredients are Foodmate's area of expertise. These are a few of the products they sell. In 2023, Barth Industrial Automation was acquired by Foodmate B.V., a prominent global manufacturer and designer of poultry processing equipment and a part of the Duravant family of operating companies.
August 2022: Roots Brands introduced a supplement that enhances youth by combining hydrolyzed bovine collagen and entire colostrum powder. GMBMY claims to help with skin hydration, suppleness, and wrinkle reduction by utilizing the ability of bovine collagen to stimulate people's production of kinds I and III collagen.
March 2022: Aleph Farms has said that it is adding a novel platform for the manufacture of collagen through cell culture to its range of products. Aleph Farms' research center has a component called Aleph Frontiers that focuses on creating innovative products and technology for potential commercialization.
| Report Attribute/Metric | Details |
| Market Size 2022 | USD 1.2 Billion |
| Market Size 2023 | USD 1.33 Billion |
| Market Size 2032 | USD 2.97 Billion |
| Compound Annual Growth Rate (CAGR) | 10.60% (2024-2032) |
| Base Year | 2023 |
| Market Forecast Period | 2024-2032 |
| Historical Data | 2019- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Application, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | China, Japan, India, Australia, South Korea, Germany, France, UK, Italy, and Spain |
| Key Companies Profiled | Rousselot, BBI Solution, Foodmate Co. Ltd, Botiss Biomaterials GmbH, Medtronic PLC, Kyeron, Collagen Matrix Inc. |
| Key Market Opportunities | · expanding research and development efforts for the creation of regenerative and wound-healing medications |
| Key Market Dynamics | · The items' widespread application in wound care and cartilage repairs is anticipated to fuel market expansion. |
Frequently Asked Questions (FAQ) :
In 2023, the market for Bovine-based Collagen for Biomedical Applications was estimated to be worth USD 1.2 billion worldwide.
From 2024 to 2032, a compound annual growth rate (CAGR) of 10.60% is predicted for the global market.
North America held the most market share worldwide.
The key players in the market are Rousselot, BBI Solution, Foodmate Co. Ltd, Botiss Biomaterials GmbH, Medtronic PLC, Kyeron, Collagen Matrix Inc, and others.
In 2023, the market was dominated by the Bone Graft Substitutes sector.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
